|
|
|
IBCSG 34-05 / SWOG 0230 (POEMS)
Phase III of LHRH analog administration during chemotherapy to reduce ovarian failure following chemotherapy in early stage, hormone-receptor breast cancer
Prevention Of Early Menopause Study - POEMS
DESIGN

Note: Participation in an adjuvant treatment trial does not, in general, exclude patients from POEMS. If you would like to register patients from IBCSG 22-00 also into POEMS, those randomized into Arm A of IBCSG 22-00 would be eligible. Only patients randomized to the maintenance therapy arm would not be eligible for POEMS. Patients could, therefore, only participate in both studies if, following randomization to the standard arm, a one week delay before starting chemotherapy (which is required if randomized to the intervention arm on POEMS) is permissible.
Results & Publications
Presentations
- POEMS Prevention Of Early Menopause (November 2006)
|
|
Study ChairsIBCSG: Dr. Kelly-Anne Phillips - Melbourne, Australia SWOG: Dr. Halle C. F. Moore - Cleveland, USA StatisticianProf. RIchard Gelber Trial CoordinatorsAnn Lange, Emma MacDonald Frontier Science (Scotland) Ltd. Grampian View Kincraig, Kingussie PH21 1NA Phone: +44 1540 651 000 Fax: +44 1540 651 007 Email: s0230@frontier-science.uk Date of ActivationMarch 15, 2006 Targeted Accrual416 patients
Results & Publications
News
18.06.2010:
CMF chemotherapy is effective for triple-negative, node-negative breast cancer in IBCSG Trials VIII
05.05.2010:
A few impressions from our audits
27.01.2010:
First issue of SOLE flash, the short newsletter for IBCSG 35-07 SOLE
All News
|
|